|4Sep 22, 6:51 PM ET

Bohen Sean 4

4 · Olema Pharmaceuticals, Inc. · Filed Sep 22, 2022

Insider Transaction Report

Form 4
Period: 2022-09-21
Bohen Sean
DirectorPRESIDENT AND CEO
Transactions
  • Award

    Common Stock

    2022-09-21+20,00074,279 total
Footnotes (2)
  • [F1]The weighted average purchase price for the transaction reported was $3.16, and the range of prices were between $3.15 and $3.19. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.
  • [F2]Includes 5 shares acquired under the issuer's Employee Stock Purchase Plan.

Documents

1 file
  • 4
    form4-09222022_030957.xmlPrimary